Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

我们需要有色素损伤诊所吗?

S H Ibbotson, M G Dahl, P M Farr

    Lancet (London, England)
    |November 18, 1995
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease.

    The British journal of dermatology·2021
    Same author

    Photodiagnostic services in the UK and Republic of Ireland: a British Photodermatology Group Workshop Report.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Minimal, superficial DNA damage in human skin from filtered far-ultraviolet C.

    The British journal of dermatology·2021
    Same author

    Is there an optimal irradiation dose for photodynamic therapy: 37 J cm<sup>-2</sup> or 75 J cm<sup>-2</sup> ?

    The British journal of dermatology·2019
    Same author

    Efficacy of localized hand and foot phototherapy: a review of patients treated in a teaching hospital setting.

    Clinical and experimental dermatology·2018
    Same author

    Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study.

    The British journal of dermatology·2018
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章